Skip to main content
Erschienen in: Insights into Imaging 1/2020

Open Access 01.12.2020 | Educational Review

Non-neoplastic hepatopancreatobiliary lesions simulating malignancy: can we differentiate?

verfasst von: Ali Devrim Karaosmanoglu, Aycan Uysal, Musturay Karcaaltincaba, Deniz Akata, Mustafa Nasuh Ozmen, Jessica Kraeft, Peter F. Hahn

Erschienen in: Insights into Imaging | Ausgabe 1/2020

Abstract

Despite the success of cross-sectional imaging in evaluating hepatopancreatobiliary system malignancies, several non-malignant disease processes may closely mimic malignancy. Differentiating these benign diseases from malignancy may be difficult, or even impossible, even in the hands of experienced imagers. In this manuscript, we present benign mimics involving the hepatopancreatobiliary system and try to increase awareness of these potential pitfalls.
Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
ADC
Apparent diffusion coefficient
AIP
Autoimmune pancreatitis
AML
Acute myeloid leukemia
CCC
Cholangiocellular carcinoma
CT
Computed tomography
DS
Dropped gallstones
DWI
Diffusion-weighted imaging
ELA
Eosinophilic liver abscess
ERCP
Endoscopic retrograde cholangiopancreatography
HCC
Hepatocellular carcinoma
HIV
Human immunodeficiency virus
MRI
Magnetic resonance imaging
PET-CT
Positron emission tomography-computed tomography
SE
Septic embolism
T1W
T1-weighted
T2W
T2-weighted
TB
Tuberculosis
US
Ultrasound
XGC
Xanthogranulomatous cholecystitis

Key points

  • Several infectious and inflammatory conditions may mimic neoplastic processes on imaging studies and differential diagnosis may be difficult.
  • Clinical history and patient demographics are critical for correct diagnosis in addition to imaging findings.
  • Image-guided biopsy may be used for definitive differential diagnosis in selected patients.

Introduction

Despite the success of cross-sectional imaging in evaluating hepatopancreatobiliary system malignancies, several non-malignant disease processes may closely mimic malignancy [1, 2]. Differentiating these benign diseases from malignancy may be difficult, or even impossible, even in the hands of experienced imagers. In this manuscript, we present benign mimics involving the hepatopancreatobiliary system and try to increase awareness of these potential pitfalls.

Liver

Liver is probably the most commonly affected organ in the abdomen in patients with malignancy. Secondary malignancies, in the form of metastases from different sources, far exceed the primary malignant diseases of the liver. The imaging diagnosis of primary hepatic tumors including hepatocellular carcinoma (HCC) and cholangiocellular carcinomas (CCC) is usually straightforward. Metastatic involvement of the liver is common and diagnosis is generally not problematic in patients with known primary malignancies outside the liver. The early detection of metastatic liver disease is important; as it is generally a sign of advanced disease and the patient’s treatment and prognostic expectations should be adjusted accordingly in the light of this finding. Both infectious and non-infectious tumor-like conditions mimic primary and secondary liver neoplasms. We will discuss the infectious mimics first, followed by non-infectious disease processes which may simulate a liver malignancy.

Infectious mimics

The liver is frequently affected in the course of various viral, bacterial, fungal, and parasitic infections. There are several predisposing local and systemic factors which may render liver more prone to infections, including, but not limited to, immunosuppression such as related to human immunodeficiency virus (HIV), several drugs, and surgery. The differential diagnosis may be difficult and a detailed patient history is critical for correct diagnosis.

Candida albicans infection

Fungal liver infections are most common in patients with compromised immune system or in cases of hematologic malignancies. It is a manifestation of systemic fungal infection [3]. Leukemia is the most commonly encountered predisposing factor for hepatic infection from Candida albicans [3].
Ultrasound (US), computed tomography (CT), and magnetic resonance imaging (MRI) may all be used for diagnosis. On US, the echogenicity of the parenchymal candida nodules vary significantly depending on the stage of the disease [4]. The most frequent patterns is detection of multiple hypoechoic subcentimeter lesions which may closely mimic lymphomatous or leukemic involvement as well as metastases from solid organ cancers [5].
CT is a very commonly used modality for diagnosis. The infectious parenchymal foci mostly appear as round low attenuation lesions with distinct margins (Fig. 1). The size generally ranges from 2 to 20 mm. Detection of a hyperattenuating rim surrounding a hypoattenuating center (“bull's eye” appearance) in the arterial phase of the scan appears to be the most sensitive finding. In the portal-venous phase, lesions are often seen as subcentimeter hypoattenuating lesions [57].
On MRI, the nodules appear hypointense on pre-contrast T1-weighted (T1W) images with marked hyperintensity on corresponding T2-weighted (T2W) images [8, 9]. Enhancement may be seen after contrast injection [9]. The signal intensities may evolve during the course of the disease. The T2 signal gradually fades away with the response to treatment [10]. MRI was reported to be superior to CT for detection of these fungal foci [8, 10].
Differential diagnosis may be difficult and these lesions may easily be confused with metastatic disease. Clinical context and patient history are key factors for correct diagnosis. In patients who are undergoing an intensive chemotherapy for hematological malignancies, the acute emergence of fever, elevated serum CRP, and abnormal liver function tests are highly suggestive for hepatic candidiasis. Follow-up imaging after treatment may be helpful for confirming the diagnosis in some patients [11]. Sometimes, lesions paradoxically become more evident as the white count recovers and patient’s condition improves. Biopsy is typically not indicated for diagnosis in the setting of suggestive clinical history [1]. Despite all efforts, conclusive diagnosis may be impossible based on imaging findings and a percutaneous biopsy procedure may be needed for final diagnosis. Fungal micro-abscesses commonly involve the spleen as well. The spleen should be carefully scrutinized for coincident infection.

Hepatic tuberculosis

Tuberculosis (TB) is globally among the most common infectious diseases, with a variable distribution around the world. Liver involvement may be classified as either miliary form, where liver is involved in the course of systemic disease or as mass-forming localized form. The localized mass-forming (macronodular, > 2 cm) hepatic TB lesions are typically seen as focal parenchymal lesions. Hepatic tuberculomas and tuberculous abscesses may be detected in this form [1214].
As isolation of the slow-growing TB bacilli may be extremely difficult for definite diagnosis, imaging plays a crucial role in the diagnosis. Miliary lesions are typically observed as multiple subcentimeter lesions (generally less than 2 cm in size). These may be randomly distributed throughout the liver parenchyma but sometimes associated in clusters. These lesions may appear as solid or cystic, with minimal peripheral contrast enhancement. It may sometimes be difficult to differentiate them from metastases or lymphoma involvement [14].
Tuberculomas are usually detected as round lesions and may manifest as solitary or multiple lesions of varying sizes. This form is rare as compared to the miliary form and may closely mimic metastatic disease or a primary liver tumor. Tuberculomas are generally larger than 2 cm in size and are also referred to as macronodular or pseudotumoral TB [14]. Tuberculomas may be seen as hypoechoic solid masses on US; however, hyperechogenicity may also be occasionally seen [1517]. On CT, the imaging findings are generally not conclusive and they are mostly observed as hypoattenuating lesions with ill-defined borders with surrounding edema. MRI findings are also not very specific and they are usually hypointense on T1W images and hypo, iso, or hyperintense on T2W images with a peripheral hypointense rim [18]. Postcontrast images typically demonstrate peripheral rim-shaped enhancement with occasional heterogenous septal enhancement (Fig. 2) [13, 14]. The peripheral enhancement pattern may be useful for differentiating tuberculomas from neoplastic disease such as HCC and hypervascular metastases [13]. Cystic metastases from the ovaries and gastrointestinal system may look similar but detection of the perilesional edema, which is more conspicuous on T2W images, is more characteristic for a TB or pyogenic abscess over a cystic metastasis.
Hepatic TB should be considered in the differential diagnosis in patients with suggestive clinical findings such as documented TB elsewhere in the body or a history of prior TB. The demographics of the patient as well as the country of origin (in migrant and refugee patients) may also be other helpful clinical clues. However, percutaneous biopsy should be needed in certain clinical circumstances where noninvasive definitive diagnosis cannot be done.

Hydatid disease

Hydatid disease occurs in humans incidentally infected with Echinococcus granulosus and Echinococcus multilocularis. Right lobe is the most frequently involved part of the liver in patients infected with the cystic hydatid disease caused by E. granulosus. The imaging findings are highly variable depending on the stage of the disease. US primarily shows anechoic or multiseptated lesions with variable degree of calcification. CT typically demonstrates a hypodense, large lesion with walls having minimal or no enhancement (Fig. 3). In case of detaching endocyst, the detached wall appears as an undulating structure. Daughter cysts may also be visible at different stages of the disease and when present they are pathognomonic. The presence of hypointense wall on both T1- and T2-weighted images is characteristic for cystic hydatid disease. Contrast enhancement of the cyst is typically not detected on either CT or MR images, a finding that may serve as a helpful feature to differentiate degenerated hydatid cysts from cystic biliary cystadenomas/cystadenocarcinomas.
E. multilocularis infection, the alveolar form of hydatid disease, may be more difficult to differentiate from malignant lesions of the liver. The disease is biologically aggressive and typically presents as a solid, infiltrative heterogenous mass with indistinct borders (Fig. 4). There may be small cysts. Nodular and dystrophic calcifications may be detected (Fig. 5) [1]. On CT, the mass also typically includes hypoattenuating areas corresponding to necrosis and parasitic tissue. In certain cases, E. multilocularis infection may simulate a large hemangioma or a cholangiocellular carcinoma. There may be mild delayed peripheral enhancement, which corresponds to the fibroinflammatory peripheral rim, in both postcontrast CT and MRI studies (Fig. 6) [19]. On MRI, the lack of diffusion restriction in the mass is a helpful finding for differentiating alveolar echinococcosis from malignant neoplasms such as cholangiocarcinoma [19]. Familiarity with the characteristic imaging findings of alveolar echinococcosis with supportive serologic and clinical information is essential for diagnosis in patients from endemic regions.
Percutaneous treatment may be successfully used for treatment of E. granulosus infection but surgery is typically indicated for E. multilocularis infections. The most fearsome potential complication of percutaneous treatment of hydatid cyst is anaphylactic reaction. Despite the fact that it is rare, it can be fatal and therefore the interventionalist should take relevant precautionary measures before starting the procedure [20].

Pyogenic and amebic liver abscesses

Hepatic abscesses may be secondary to fungal, bacterial, or amebic infections. Pyogenic abscesses represent the vast majority of these abscesses with Escherichia coli and Clostridium species being the common causative agents [21]. Solitary hepatic abscesses are often cryptogenic with no clear-cut source to be identified [22, 23]. CT typically shows a hypoattenuating cystic lesion with surrounding parenchymal edema (Fig. 7). This parenchymal edema is a very useful sign for differentiating pyogenic abscesses from cystic metastases. However, it should also be noted that some solitary liver abscesses may present as mostly solid lesions with no identifiable underlying risk factor. Without perilesional edema and typical septations, liver abscess may be difficult to recognize (Fig. 8). Also, the presence of fever is not a universal feature of liver abscesses, further complicating diagnosis. The absence of centrally progressing contrast enhancement on delayed phase images and progressive enhancement in the outermost layer corresponding to the fibroinflammatory capsule of the abscess may be helpful for differentiating mostly solid appearing pyogenic abscesses from intrahepatic cholangiocarcinomas. It is also difficult to differentiate necrotic liver tumors from abscesses. Nodularity in the internal surface of the lesion wall, focal calcifications within the lesion, and the absence of perilesional edema favors necrotic neoplasm over an abscess [24]. Follow-up imaging after empirical treatment for liver abscess may also be implemented as an alternative approach for differential diagnosis. However, morphological changes may also be observed during the natural course of the disease without any therapeutic intervention. In patients where no diagnosis could be achieved in a noninvasive manner, percutaneous biopsy may be utilized for definitive treatment planning.
Amebic abscesses are caused by the protozoan Entamoeba histolytica [21]. In around 70% of the cases, a solitary abscess within the right liver lobe is detected. US typically shows a round or oval shaped, hypoechoic lesion without any significant wall echoes [25]. On contrast enhanced CT, amebic abscess usually may appear as round shaped, hypoattenuating lesions with ill-defined borders (Fig. 9). An enhancing wall and a peripheral edema are also a common feature. Also, septations may be seen within the abscess cavity [24, 26].

Eosinophilic liver abscess

Eosinophilic liver abscess (ELA) consists of focal eosinophil-related parenchymal liver necrosis. Hepatic eosinophilia and hepatic eosinophilic granuloma are alternative terms for this clinical entity. Most cases are incidentally diagnosed in asymptomatic patients who also typically have peripheral eosinophilia. The disease usually runs a benign course. Hepatic migration of parasitic larvae has been implicated in the etiology; however, medications, allergic, and neoplastic diseases have also been considered in the pathogenesis [27]. This is a rare clinical condition and may mimic liver metastases on imaging studies (Fig. 10) [28].
Typically, ELAs are seen as multiple small, hypodense, and oval-shaped lesions on CT [27]. Multifocality and a history of parasitic disease may be helpful for differential diagnosis. Follow-up imaging may also show regression of the liver lesions which may be helpful for differential diagnosis. However, definitive diagnosis almost always requires histopathologic confirmation [29].

Fascioliasis of the liver

Fascioliasis is an infection caused by Fasciola hepatica flatworm. The larvae are acquired by ingesting infected water. The parasites may stay dormant within the liver parenchyma for years and this chronic presence typically leads to chronic parenchymal inflammation [30]. The typical imaging findings include tunnel-shaped microabscesses and necrotic parenchymal cavities along the migration tract of the larva. These tunnels often extend from Glisson’s capsule to the central portions of the liver [30]. Peripheral eosinophilia is a common finding in fascioliasis and may be helpful to reach a correct diagnosis [31]. Imaging presentation may mimic malignant processes in some patients (Fig. 11). Histopathologic diagnosis may be necessary in these patients for correct diagnosis, particularly without antecedent imaging findings that show tunneling tracts.

Rare granulomatous liver infections

Spirochetal infections of the liver are rare in the post-antibiotic era [32]. Spirochetal hepatitis can lead to cirrhosis, and the detection of gummas, caseating, and non-caseating granulomas and focal necrosis around the hepatic veins are characteristic histologic findings [33, 34]. Liver involvement may be seen in secondary and tertiary stages of syphilis. Focal gumma may develop in the liver typically 1–10 years after the original infection [35]. There is not much information in the imaging literature due to the rarity of hepatic involvement. However, it appears that low attenuation lesions with peripheral enhancement on CT (Fig. 12) are a potential finding. Calcification may also be rarely present [36, 37].
Fransicella tularensis is a Gram-negative coccobacillus endemic to many parts of North America. The most common presentation is the ulceroglandular form. Untreated disease can spread to multiple organs. Liver involvement is common and may be observed in 75% of cases with extralymphatic organ involvement [38]. The spectrum of findings in tularemia is considered to be in the spectrum of granulomatous hepatitis [39]. Visible hepatic abscess can form, which in our experience can appear quite solid on CT (Fig. 13).
Bartonellosis is among the causes of fever of unknown origin and unusual presentations may happen in 0.3–10% of cases [40]. In cases with hepatic and splenic involvement, granulomatous inflammatory process is typically the hallmark pathologic finding. Imaging findings are non-specific but hypoenhancing or non-enhancing focal parenchymal lesions may be observed (Fig. 14a). MR imaging features are not well described, with only anecdotal case reports. T2 hyperintensity and postcontrast enhancement on T1W images are among the reported findings (Fig. 14b). Calcifications may appear within these nodules on long-term follow-up [3, 41]. The nodules may easily be confused on CT and MR with hypoenhancing metastases. It should also be noted that the disease may appear as a single mass within the liver parenchyma mimicking a primary hypoenhancing cholangiocellular carcinoma.

Actinomycosis of the liver

Actinomyces are slow growing, Gram-positive, branching bacilli. They are most frequently associated with infections in the cervicofacial region. Abdominal involvement is rare, where iliocecal area is the most frequently affected region. Hepatic infection has been reported to be seen in 15% of those with abdominal infection and, overall, represents 5% of all cases with actinomycosis [42]. Imaging studies may reveal multiple or solitary lesions, a single hypoattenuating mass the most common presentation (Fig. 15) [43]. T1 hypointensity, with variable contrast enhancement, and associated T2 hyperintensity are the commonly encountered findings on MRI studies (Fig. 16) [44].

Pneumocystis jirovecii infection of the liver

Pneumocystis jirovecii is a common opportunistic infection in immunocompromised and HIV-infected patients and lung is the most commonly involved organ. Liver involvement is not common, but when present, hypodense lesions within the liver and spleen may be seen on CT (Fig. 17). The differential diagnosis from a neoplastic process is even more difficult when infection is the presenting symptom of unrecognized retroviral infection. In our limited experience, lesions are almost always multiple rather than solitary. Clinical and medication history as well as the immune status of the patient are key factors for the correct diagnosis. The presence of associated lung findings may also be helpful.

Sarcoidosis

Sarcoidosis is a systemic granulomatous disease. The exact etiology is obscure and the detection of non-caseating granulomas on pathology specimens is characteristic for this disease. Lungs are the most commonly involved organs but virtually any organ can be affected in the course of the disease [45]. Liver is the third most commonly affected organ after lung and lymph nodes and in most cases hepatic involvement occurs in the course of systemic disease. However, isolated liver involvement had also been reported [45]. The detection of liver involvement may be delayed as most of the affected patients are asymptomatic [46]. Although the liver is commonly involved, in only 5% of sarcoid cases will liver lesions be detected with CT [47]. Liver involvement in sarcoidosis may present in diffuse or focal nodular patterns [46]. Focal lesions are typically small and randomly scattered throughout the liver parenchyma. On CT, the lesions are mostly hypoattenuating without significant contrast enhancement (Fig. 18). MR imaging may also be helpful for lesion detection. Concurrent splenic lesions should be sought, as these are often more readily detected than sarcoid in the liver. From an imaging standpoint, differentiation from metastatic disease, lymphomatous involvement, or other infectious processes may be difficult without relevant clinical and serologic information.
Elevated serum ACE levels are a relatively common finding which may act as a supportive information to reach the diagnosis. Despite best efforts, image-guided percutaneous biopsy may be necessary for definitive diagnosis [45].
IgG4-related disease commonly affects the liver and the biliary system. Histopathologically IgG4-related hepatic disease is characterized as a fibroinflammatory condition with dense lymphoplasmocytic infiltrate rich in IgG4-positive plasma cells with or without elevated serum IgG4 levels [48]. Focal parenchymal mass with well-defined borders is relatively rare in patients with liver involvement [49]. Differentiation from liver malignancy may be extremely difficult without proper history and pathological analysis (Figs. 19 and 20) [48, 50].

Inflammatory pseudotumor of the liver

Inflammatory pseudotumor of the liver was first described in 1953 and more than 200 patients have since been reported [51, 52]. The etiology remains largely unknown but autoimmune reactions, infectious hepatitis, and bacterial infections have all been implicated in the etiology [53]. In certain patients, differential diagnosis from neoplastic liver lesions may necessitate percutaneous biopsy and histopathologic confirmation. Inflammatory pseudotumors have been reported to simulate HCC in patients with viral hepatitis [53].
On US, lesions generally appear hypoechoic in the right liver lobe [54]. CT findings are highly variable. Early arterial phase enhancement mimicking an HCC or hypervascular metastasis, peripheral enhancement mimicking a cholangiocellular carcinoma or metastasis, and wash-out in the venous phase suggesting an HCC have all been reported [54, 55]. On MRI, these lesions appear hypointense on pre-contrast T1W images and iso-hyperintense on T2W images. Heterogenous or peripheral enhancement is common after contrast injection (Fig. 21) [56, 57].

Dropped gallstones

Dropped gallstones (DS) may be seen after approximately 7% of laparoscopic cholecystectomies as a result of the rupture of gallbladder wall during dissection and removal of the gallbladder [58]. These DSs may become symptomatic in rare instances. Correct diagnosis might be extremely challenging and delayed due to atypical modes of clinical presentation and unexpected locations of these DSs [59]. Meticulous dissection and aspiration of the gallbladder during surgery comprise important factors to prevent this complication [60]. These DSs may become symptomatic with a median time interval of 5 months after the surgery, but symptoms were reported to appear even 20 years after the procedure [58].
Focal inflammation with abscess and fistula tract formation are relatively common complications. The detection of hyperdense structures within necrotic abscesses (in cases with dropped calcified gallstones) may be an important diagnostic clue. The location of the collection/inflammation adjacent to the liver capsule may also be regarded as a suggestive finding. Other rare complications include erosion into large bowel and bowel obstruction due to adhesion formation [58]. In patients with known malignant tumors, inflammation in hepatorenal fossa due to dropped gallstones may mimic an implant and histopathologic evaluation may be necessary (Fig. 22). Dropped gallstones may also be seen in the gallbladder fossa and differentiation from a primary focal liver malignancy may again be extremely difficult (Fig. 23).

Gallbladder and the biliary system

Biliary dilatation and asymmetric gallbladder (GB) wall thickening are fearsome imaging findings, often indicating a pancreatobiliary system cancer or biliary stone disease. Despite these common entities, several non-neoplastic diseases may also affect the biliary system and may cause biliary system abnormalities. Primary adenocarcinoma of the gallbladder is a highly aggressive malignancy with grave prognosis. In certain patients, the gallbladder may be completely replaced by the tumor, a finding that makes difficult to conclude the source organ. However, the diagnosis may be generally made based on imaging findings. Despite this relative ease of diagnosis, one should keep in mind the several non-neoplastic mimickers of this cancer including xanthogranulomatous cholecystitis [61].

Gallbladder-associated pseudomasses

Adenocarcinoma of the gallbladder is one of the deadliest hepatobiliary cancers. Some small cancers are incidental discoveries at cholecystectomy. When diagnosed with GB cancer by imaging, most patients are at an advanced stage with local lymph node metastases and parenchymal liver invasion. For these reasons, correct diagnosis is of critical importance and potential mimics should be considered.
Xanthogranulomatous cholecystitis (XGC) is a rare variant of chronic cholecystitis. Despite the fact that it is a benign disease, the inflammatory process may be infiltrative and locally destructive. There is asymmetrical thickening of the gallbladder wall, with the inflammatory process extending into liver parenchyma, omentum, and duodenum (Fig. 24) [62]. Because of close resemblance of the imaging findings, patients with XGC might undergo radical surgical procedures with a misdiagnosis of primary gallbladder adenocarcinoma. The adjacent liver parenchyma may also show abnormal enhancement which may falsely suggest parenchymal invasion. Enlarged lymph nodes may be seen in both gallbladder cancer and XGC, and cholelithiasis is common in both. Intramural hypoattenuating nodules on CT in the thickened gallbladder wall may serve as a helpful finding for diagnosing XGC over gallbladder adenocarcinoma. On MRI, the detection of the fatty content in these nodules could be detected by chemical-shift MR imaging [63]. Cholecystectomy may be necessary for definitive diagnosis in certain patients [62].

Tuberculous cholangitis

Clinical presentation of biliary involvement in patients with tuberculous cholangitis is usually insidious. Among the commonly reported symptoms are abdominal pain, fever, weight loss, and jaundice [64]. Imaging findings may mimic neoplastic disorders especially in patients with significant mural contrast enhancement and sclerosing biliary obstruction (Fig. 25). Endoscopic retrograde cholangiopancreatography (ERCP) findings may mimic primary sclerosing cholangitis with alternating stenotic and dilated biliary radicals and associated wall irregularities within bile duct walls. These ERCP findings may be seen in other conditions such as leukemia, lymphoma, solid tumor metastases, and hepatic amyloidosis [65].
IgG4-related sclerosing cholangitis is frequently associated with autoimmune pancreatitis (AIP). Bile ducts are the most commonly involved body part aside from the pancreas in IgG4-related disease. However, isolated biliary involvement may also be seen without obvious pancreatic involvement [66, 67]. Histopathologically, biliary involvement is characterized with infiltration of bile ducts with IgG4-positive plasma cells and associated extensive fibrosis. Both intrahepatic and extrahepatic bile ducts may be involved in IgG4-related sclerosing cholangitis in diffuse or isolated patterns. Intrapancreatic distal portion of the common bile duct is the most commonly affected biliary segment [66, 68]. Wall thickening and irregularity with associated contrast enhancement and luminal stenosis are typical imaging findings. Focal involvement of distal common bile duct or hilar hepatic involvement with upstream dilation of biliary system may closely mimic a hepatic cholangiocarcinoma or a pancreatic head mass (Fig. 26) [66, 68].
On CT, biliary involvement is typically seen as focal or diffuse wall thickening with contrast enhancement. Biliary stricture with associated enhancing soft tissue mass may also be seen on postcontrast studies which can simulate a cholangiocarcinoma [66, 68].
In IgG4-related sclerosing cholangitis, CT and MRI typically demonstrates concentric soft-tissue thickening of the bile duct wall with homogeneous enhancement in the delayed phase. Associated luminal irregularities are found not only in stenotic segments or in the vicinity of the soft tissue mass but also in areas without any sign of stenosis [68]. Although a thick, annular rind of soft-tissue encasing the affected duct suggests IgG4-related sclerosing cholangitis, this finding may also be seen, to a milder degree, in patients with primary sclerosing cholangitis or infectious cholangitis [66]. Although elevated serum IgG4 levels and associated extrabiliary disease (especially the involvement of the pancreas or the kidneys) may act as a supportive finding, in some patients percutaneous or endoscopic biopsy may be necessary.

Pancreas

Pancreatic malignancies have significant morbidity and mortality. Pancreatic adenocarcinoma has dismal survival rates which have not changed significantly over the last few decades, despite advances in medical and surgical oncology. Around 90% of patients who were diagnosed with pancreatic cancer are expected to die eventually from the disease [69]. Acute or chronic pancreatitis are common pancreatic diseases that may sometimes be confused with pancreatic cancers.
AIP is the most common manifestation of IgG4-related systemic disease. AIP type 1 (also known as lymphoplasmacytic sclerosing pancreatitis) is seen mostly in middle aged men, whereas AIP type 2 is frequently a disease of a younger population [67]. Type 1 AIP represents the pancreatic manifestation of systemic IgG4-related disease and type 2 AIP is typically a pancreas-specific disorder with no extrapancreatic involvement (e.g., proximal biliary stricture, submandibular gland involvement, or retroperitoneal fibrosis) [70]. Imaging-based differentiation between these two subtypes is currently not possible and differentiation is based mainly on histopathological evaluation [71].
From an imaging standpoint, diffuse enlargement of the pancreas is a commonly encountered finding but focal or mass-like enlargement is not unusual. Diffuse enlargement was reported in between 11 and 56% of patients, whereas focal or mass-like enlargement was observed in 28–59% of the cases (Fig. 27) [72]. Irregular narrowing of the main pancreatic duct is another important feature [67]. Peripancreatic fat planes are typically preserved with no evidence of fluid collection or peripancreatic inflammation, which are commonly seen in acute pancreatitis.
Given the overlap of clinical and imaging features between focal AIP and pancreatic cancer, several studies have sought to differentiate AIP from pancreatic malignancies. Dilation of the main pancreatic duct is mild in patients with AIP as compared to pancreatic adenocarcinoma. Indeed, upstream dilatation of the main pancreatic duct is rarely greater than 4 mm in patients with AIP [73]. The pancreatic duct penetrating through the pseudomass, also known as the duct-penetrating sign, is considered to be a helpful sign for differentiating AIP from pancreatic cancer [67].

Focal pancreatitis mimicking pancreatic neoplasm

Mass forming focal pancreatitis, by definition, refers to a focal inflammatory process which can sometimes closely mimic pancreatic cancer. Imaging differentiation between a cancer and mass forming focal pancreatitis can sometimes be extremely difficult or impossible [74].
Several studies based on either CT or MRI found no meaningful difference between these two entities in signal characteristics or contrast enhancement patterns [75]. Both are hypo- or isoattenuating to pancreatic parenchyma on CT and are hypointense or isointense on T1-weighted MRI images (Fig. 28). Gradual progressive enhancement is common after contrast injection. The differentiation from a primary adenocarcinoma may be particularly difficult when the clinical presentation does not suggest acute pancreatitis. The abundance of fibrosis in both conditions is probably the underlying reason for these similar imaging features [76]. Histopathologic evaluation or close follow-up imaging is almost always indicated for diagnosis.

Pancreatic tuberculosis

Isolated pancreatic tuberculosis (TB) is an extremely rare clinical entity, even in parts of the world where TB is prevalent. Clinical and imaging findings may closely mimic pancreatic cancer and differential diagnosis may be difficult [77]. Abdominal pain, jaundice, and weight loss are the most common presenting symptoms in both clinical situations [78]. The disease may focally or diffusely involve the pancreas. Focal involvement typically presents as a hypoattenuating mass on CT (Fig. 29) and histopathologic examination is almost always necessary for diagnosis. Enlarged peripancreatic lymph nodes with central necrosis may be seen as an associating finding in some patients [79]. Diffuse involvement, a rare presentation of pancreatic adenocarcinoma, may also be difficult to differentiate from primary pancreatic malignancy.

Pancreatic septic embolus

Septic embolism (SE) is a potentially mortal cause of infection. It can appear in both the early and late phases of infectious diseases. Septic emboli to the brain and the lung have been most extensively studied. Embolic infarcts within pancreatic parenchyma have been reported in patients with multi-organ embolization where brain, spleen and myocardium are also affected [80]. Abdominal pain is a common symptom with associated leukocytosis and elevated amylase levels [81, 82].
There is limited information in the literature regarding the imaging findings of pancreatic SE. The embolic foci appeared as hypoattenuating focal lesion within the pancreatic parenchyma, thus mimicking a neoplastic process (Fig. 30). Multifocal hypodense foci may also mimic lymphomatous infiltration or metastases to the pancreas. Despite the fact that multifocal pancreatic adenocarcinoma is rare, that diagnosis should also be considered in the differential diagnosis. Close imaging follow-up after antibiotic treatment is advisable both for confirming diagnosis and for evaluating the response to treatment. Involvement of different organs due to septic emboli, in addition to pancreas, may be a helpful finding for correct differential diagnosis.

Conclusion

Several non-neoplastic abnormalities may simulate malignant disease and differential diagnosis may be difficult by imaging alone. However, the imaging characteristics and enhancement pattern of the lesion with the assessment of vascular involvement may be very helpful. Co-involvement of the spleen should raise the possibility of an infectious or inflammatory process, as should discrete cystic foci in a solid lesion. Multimodality imaging in relevant cases may also be extremely useful by delineating the different imaging aspects of the same lesion. Besides all these parameters, patient demographics, clinical symptoms, and signs such as fever, laboratory data, tumor markers, short-term changes of imaging findings, and imaging findings of diffusion-weighted imaging (DWI) should all be taken into account for correct diagnosis. Close communication with the referring physician is another important point to be considered. It should be borne in mind that many unusual infectious and non-infectious inflammatory lesions may be sampled for diagnosis with imaging guidance and that this approach is safe in experienced hands and should be liberally used as a tool for early diagnosis.
Not applicable.
Not applicable.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Alobaidi M, Shirkhoda A (2004) Benign focal liver lesions: discrimination from malignant mimickers. Curr Probl Diagn Radiol 33(6):239–253PubMedCrossRef Alobaidi M, Shirkhoda A (2004) Benign focal liver lesions: discrimination from malignant mimickers. Curr Probl Diagn Radiol 33(6):239–253PubMedCrossRef
2.
Zurück zum Zitat Gandhi NS, Feldman MK, Le O, Morris-Stiff G (2018) Imaging mimics of pancreatic ductal adenocarcinoma. Abdom Radiol (NY) 43(2):273–284CrossRef Gandhi NS, Feldman MK, Le O, Morris-Stiff G (2018) Imaging mimics of pancreatic ductal adenocarcinoma. Abdom Radiol (NY) 43(2):273–284CrossRef
3.
Zurück zum Zitat Mortele KJ, Segatto E, Ros PR (2004) The infected liver: radiologic-pathologic correlation. Radiographics 24(4):937–955PubMedCrossRef Mortele KJ, Segatto E, Ros PR (2004) The infected liver: radiologic-pathologic correlation. Radiographics 24(4):937–955PubMedCrossRef
4.
Zurück zum Zitat Pastakia B, Shawker TH, Thaler M, O'Leary T, Pizzo PA (1988) Hepatosplenic candidiasis: wheels within wheels. Radiology 166(2):417–421PubMedCrossRef Pastakia B, Shawker TH, Thaler M, O'Leary T, Pizzo PA (1988) Hepatosplenic candidiasis: wheels within wheels. Radiology 166(2):417–421PubMedCrossRef
5.
Zurück zum Zitat Cornely OA, Bangard C, Jaspers NI (2015) Hepatosplenic candidiasis. Clin Liver Dis (Hoboken) 6(2):47–50CrossRef Cornely OA, Bangard C, Jaspers NI (2015) Hepatosplenic candidiasis. Clin Liver Dis (Hoboken) 6(2):47–50CrossRef
6.
Zurück zum Zitat Metser U, Haider MA, Dill-Macky M, Atri M, Lockwood G, Minden M (2005) Fungal liver infection in immunocompromised patients: depiction with multiphasic contrast-enhanced helical CT. Radiology 235(1):97–105PubMedCrossRef Metser U, Haider MA, Dill-Macky M, Atri M, Lockwood G, Minden M (2005) Fungal liver infection in immunocompromised patients: depiction with multiphasic contrast-enhanced helical CT. Radiology 235(1):97–105PubMedCrossRef
7.
Zurück zum Zitat Berlow ME, Spirt BA, Weil L (1984) CT follow-up of hepatic and splenic fungal microabscesses. J Comput Assist Tomogr 8(1):42–45PubMedCrossRef Berlow ME, Spirt BA, Weil L (1984) CT follow-up of hepatic and splenic fungal microabscesses. J Comput Assist Tomogr 8(1):42–45PubMedCrossRef
8.
Zurück zum Zitat Anttila VJ, Lamminen AE, Bondestam S et al (1996) Magnetic resonance imaging is superior to computed tomography and ultrasonography in imaging infectious liver foci in acute leukaemia. Eur J Haematol 56(1-2):82–87CrossRef Anttila VJ, Lamminen AE, Bondestam S et al (1996) Magnetic resonance imaging is superior to computed tomography and ultrasonography in imaging infectious liver foci in acute leukaemia. Eur J Haematol 56(1-2):82–87CrossRef
9.
Zurück zum Zitat Semelka RC, Kelekis NL, Sallah S, Worawattanakul S, Ascher SM (1997) Hepatosplenic fungal disease: diagnostic accuracy and spectrum of appearances on MR imaging. AJR Am J Roentgenol 169(5):1311–1316PubMedCrossRef Semelka RC, Kelekis NL, Sallah S, Worawattanakul S, Ascher SM (1997) Hepatosplenic fungal disease: diagnostic accuracy and spectrum of appearances on MR imaging. AJR Am J Roentgenol 169(5):1311–1316PubMedCrossRef
10.
Zurück zum Zitat Semelka RC, Patrick Shoenut J, Greenberg HM, Bow EJ (1992) Detection of acute and treated lesions of hepatosplenic candidiasis: comparison of dynamic contrast-enhanced CT and MR imaging. J Magn Reson Imaging 2(3):341–345PubMedCrossRef Semelka RC, Patrick Shoenut J, Greenberg HM, Bow EJ (1992) Detection of acute and treated lesions of hepatosplenic candidiasis: comparison of dynamic contrast-enhanced CT and MR imaging. J Magn Reson Imaging 2(3):341–345PubMedCrossRef
11.
Zurück zum Zitat Shirkhoda A, Lopez-Berestein G, Holbert JM, Luna MA (1986) Hepatosplenic fungal infection: CT and pathologic evaluation after treatment with liposomal amphotericin B. Radiology 159(2):349–353PubMedCrossRef Shirkhoda A, Lopez-Berestein G, Holbert JM, Luna MA (1986) Hepatosplenic fungal infection: CT and pathologic evaluation after treatment with liposomal amphotericin B. Radiology 159(2):349–353PubMedCrossRef
12.
Zurück zum Zitat Balci NC, Tunacı A, Akınci A, Cevikbaş U (2001) Granulomatous hepatitis: MRI findings. Magn Reson Imaging 19(8):1107–1111PubMedCrossRef Balci NC, Tunacı A, Akınci A, Cevikbaş U (2001) Granulomatous hepatitis: MRI findings. Magn Reson Imaging 19(8):1107–1111PubMedCrossRef
13.
Zurück zum Zitat Karaosmanoglu AD, Onur MR, Sahani DV, Tabari A, Karcaaltincaba M (2016) Hepatobiliary tuberculosis: imaging findings. AJR Am J Roentgenol 207(4):694–704PubMedCrossRef Karaosmanoglu AD, Onur MR, Sahani DV, Tabari A, Karcaaltincaba M (2016) Hepatobiliary tuberculosis: imaging findings. AJR Am J Roentgenol 207(4):694–704PubMedCrossRef
14.
Zurück zum Zitat Kakkar C, Polnaya AM, Koteshwara P, Smiti S, Rajagopal KV, Arora A (2015) Hepatic tuberculosis: a multimodality imaging review. Insights Imaging 6(6):647–658PubMedPubMedCentralCrossRef Kakkar C, Polnaya AM, Koteshwara P, Smiti S, Rajagopal KV, Arora A (2015) Hepatic tuberculosis: a multimodality imaging review. Insights Imaging 6(6):647–658PubMedPubMedCentralCrossRef
15.
16.
Zurück zum Zitat Jain R, Sawhney S, Gupta RG, Acharya SK (1999) Sonographic appearances and percutaneous management of primary tuberculous liver abscess. J Clin Ultrasound 27(3):159–163PubMedCrossRef Jain R, Sawhney S, Gupta RG, Acharya SK (1999) Sonographic appearances and percutaneous management of primary tuberculous liver abscess. J Clin Ultrasound 27(3):159–163PubMedCrossRef
17.
Zurück zum Zitat Mills P, Saverymuttu S, Fallowfield M, Nussey S, Joseph AE (1990) Ultrasound in the diagnosis of granulomatous liver disease. Clin Radiol 41(2):113–115PubMedCrossRef Mills P, Saverymuttu S, Fallowfield M, Nussey S, Joseph AE (1990) Ultrasound in the diagnosis of granulomatous liver disease. Clin Radiol 41(2):113–115PubMedCrossRef
18.
Zurück zum Zitat Hickey N, McNulty JG, Osborne H, Finucane J (1999) Acute hepatobiliary tuberculosis: a report of two cases and a review of the literature. Eur Radiol 9(5):886–889PubMedCrossRef Hickey N, McNulty JG, Osborne H, Finucane J (1999) Acute hepatobiliary tuberculosis: a report of two cases and a review of the literature. Eur Radiol 9(5):886–889PubMedCrossRef
19.
Zurück zum Zitat Kantarci M, Bayraktutan U, Karabulut N et al (2012) Alveolar echinococcosis: spectrum of findings at cross-sectional imaging. Radiographics 32(7):2053–2070PubMedCrossRef Kantarci M, Bayraktutan U, Karabulut N et al (2012) Alveolar echinococcosis: spectrum of findings at cross-sectional imaging. Radiographics 32(7):2053–2070PubMedCrossRef
20.
Zurück zum Zitat Akhan O, Ozmen MN, Dincer A, Sayek I, Göçmen A (1996) Liver hydatid disease: long-term results of percutaneous treatment. Radiology 198(1):259–264PubMedCrossRef Akhan O, Ozmen MN, Dincer A, Sayek I, Göçmen A (1996) Liver hydatid disease: long-term results of percutaneous treatment. Radiology 198(1):259–264PubMedCrossRef
21.
Zurück zum Zitat Mortele KJ, Ros PR (2001) Cystic focal liver lesions in the adult: differential CT and MR imaging features. Radiographics 21(4):895–910PubMedCrossRef Mortele KJ, Ros PR (2001) Cystic focal liver lesions in the adult: differential CT and MR imaging features. Radiographics 21(4):895–910PubMedCrossRef
22.
Zurück zum Zitat Land MA, Moinuddin M, Bisno AL (1985) Pyogenic liver abscess: changing epidemiology and prognosis. South Med J 78(12):1426–1430PubMedCrossRef Land MA, Moinuddin M, Bisno AL (1985) Pyogenic liver abscess: changing epidemiology and prognosis. South Med J 78(12):1426–1430PubMedCrossRef
23.
Zurück zum Zitat Ralls PW (1998) Focal inflammatory disease of the liver. Radiol Clin North Am 36(2):377–389PubMedCrossRef Ralls PW (1998) Focal inflammatory disease of the liver. Radiol Clin North Am 36(2):377–389PubMedCrossRef
24.
Zurück zum Zitat Bächler P, Baladron MJ, Menias C et al (2016) Multimodality Imaging of liver infections: differential diagnosis and potential pitfalls. Radiographics 36(4):1001–1023PubMedCrossRef Bächler P, Baladron MJ, Menias C et al (2016) Multimodality Imaging of liver infections: differential diagnosis and potential pitfalls. Radiographics 36(4):1001–1023PubMedCrossRef
25.
Zurück zum Zitat Ralls PW, Colletti PM, Quinn MF, Halls J (1982) Sonographic findings in hepatic amebic abscess. Radiology 145(1):123–126PubMedCrossRef Ralls PW, Colletti PM, Quinn MF, Halls J (1982) Sonographic findings in hepatic amebic abscess. Radiology 145(1):123–126PubMedCrossRef
26.
Zurück zum Zitat Radin DR, Ralls PW, Colletti PM, Halls JM (1988) CT of amebic liver abscess. AJR Am J Roentgenol 150(6):1297–1301PubMedCrossRef Radin DR, Ralls PW, Colletti PM, Halls JM (1988) CT of amebic liver abscess. AJR Am J Roentgenol 150(6):1297–1301PubMedCrossRef
27.
Zurück zum Zitat Kwon JW, Kim TW, Kim KM et al (2011) Clinical features of clinically diagnosed eosinophilic liver abscesses. Hepatol Int 5(4):949–954PubMedCrossRef Kwon JW, Kim TW, Kim KM et al (2011) Clinical features of clinically diagnosed eosinophilic liver abscesses. Hepatol Int 5(4):949–954PubMedCrossRef
29.
Zurück zum Zitat Yoo SY, Han JK, Kim YH, Kim TK, Choi BI, Han MC (2003) Focal eosinophilic infiltration in the liver: radiologic findings and clinical course. Abdom Imaging 28(3):326–332PubMedCrossRef Yoo SY, Han JK, Kim YH, Kim TK, Choi BI, Han MC (2003) Focal eosinophilic infiltration in the liver: radiologic findings and clinical course. Abdom Imaging 28(3):326–332PubMedCrossRef
30.
Zurück zum Zitat Lim JH, Mairiang E, Ahn GH (2008) Biliary parasitic diseases including clonorchiasis, opisthorchiasis and fascioliasis. Abdom Imaging 33(2):157–165PubMedCrossRef Lim JH, Mairiang E, Ahn GH (2008) Biliary parasitic diseases including clonorchiasis, opisthorchiasis and fascioliasis. Abdom Imaging 33(2):157–165PubMedCrossRef
31.
Zurück zum Zitat Kaya M, Beştaş R, Cetin S (2011) Clinical presentation and management of Fasciola hepatica infection: single-center experience. World J Gastroenterol 17(44):4899–4904PubMedPubMedCentralCrossRef Kaya M, Beştaş R, Cetin S (2011) Clinical presentation and management of Fasciola hepatica infection: single-center experience. World J Gastroenterol 17(44):4899–4904PubMedPubMedCentralCrossRef
33.
Zurück zum Zitat Maincent G, Labadie H, Fabre M et al (1997) Tertiary hepatic syphilis. A treatable cause of multinodular liver. Dig Dis Sci 42(2):447–450 Maincent G, Labadie H, Fabre M et al (1997) Tertiary hepatic syphilis. A treatable cause of multinodular liver. Dig Dis Sci 42(2):447–450
34.
Zurück zum Zitat Veeravahu M (1985) Diagnosis of liver involvement in early syphilis. A critical review. Arch Intern Med 145(1):132–134PubMedCrossRef Veeravahu M (1985) Diagnosis of liver involvement in early syphilis. A critical review. Arch Intern Med 145(1):132–134PubMedCrossRef
35.
36.
Zurück zum Zitat Peeters L, Van WV, der Perre Van C, Lagrange W, Verbeke M (2005) Tertiary syphilis presenting as hepatic bull's eye lesions. Acta Gastroenterol Belg 68(4):435–439 Peeters L, Van WV, der Perre Van C, Lagrange W, Verbeke M (2005) Tertiary syphilis presenting as hepatic bull's eye lesions. Acta Gastroenterol Belg 68(4):435–439
37.
Zurück zum Zitat Shapiro MP, Gale ME (1987) Tertiary syphilis of the liver: CT appearance. J Comput Assist Tomogr 11(3):546–547PubMedCrossRef Shapiro MP, Gale ME (1987) Tertiary syphilis of the liver: CT appearance. J Comput Assist Tomogr 11(3):546–547PubMedCrossRef
38.
Zurück zum Zitat Zaidi SA, Singer C (2002) Gastrointestinal and hepatic manifestations of tickborne diseases in the United States. Clin Infect Dis 34(9):1206–1212PubMedCrossRef Zaidi SA, Singer C (2002) Gastrointestinal and hepatic manifestations of tickborne diseases in the United States. Clin Infect Dis 34(9):1206–1212PubMedCrossRef
39.
Zurück zum Zitat Ortego TJ, Hutchins LF, Rice J, Davis GR (1986) Tularemic hepatitis presenting as obstructive jaundice. Gastroenterology 91(2):461–463PubMedCrossRef Ortego TJ, Hutchins LF, Rice J, Davis GR (1986) Tularemic hepatitis presenting as obstructive jaundice. Gastroenterology 91(2):461–463PubMedCrossRef
40.
Zurück zum Zitat Baptista MA, Lo DS, Hein N et al (2014) Cat-scratch disease presenting as multiple hepatic lesions: case report and literature review. Autops Case Rep 4(2):43–48PubMedCrossRefPubMedCentral Baptista MA, Lo DS, Hein N et al (2014) Cat-scratch disease presenting as multiple hepatic lesions: case report and literature review. Autops Case Rep 4(2):43–48PubMedCrossRefPubMedCentral
41.
Zurück zum Zitat Stuart SM, Nowicki MJ (1998) Radiological case of the month. Cat-scratch disease with hepatic and splenic involvement. Arch Pediatr Adolesc Med 152(8):823–824PubMedCrossRef Stuart SM, Nowicki MJ (1998) Radiological case of the month. Cat-scratch disease with hepatic and splenic involvement. Arch Pediatr Adolesc Med 152(8):823–824PubMedCrossRef
43.
Zurück zum Zitat Islam T, Athar MN, Athar MK, Usman MH, Misbah B (2005) Hepatic actinomycosis with infiltration of the diaphragm and right lung: a case report. Can Respir J 12(6):336–337PubMedCrossRef Islam T, Athar MN, Athar MK, Usman MH, Misbah B (2005) Hepatic actinomycosis with infiltration of the diaphragm and right lung: a case report. Can Respir J 12(6):336–337PubMedCrossRef
44.
Zurück zum Zitat Kim HS, Park NH, Park KA, Kang SB (2007) A case of pelvic actinomycosis with hepatic actinomycotic pseudotumor. Gynecol Obstet Invest 64(2):95–99PubMedCrossRef Kim HS, Park NH, Park KA, Kang SB (2007) A case of pelvic actinomycosis with hepatic actinomycotic pseudotumor. Gynecol Obstet Invest 64(2):95–99PubMedCrossRef
45.
Zurück zum Zitat Koyama T, Ueda H, Togashi K, Umeoka S, Kataoka M, Nagai S (2004) Radiologic manifestations of sarcoidosis in various organs. Radiographics 24(1):87–104PubMedCrossRef Koyama T, Ueda H, Togashi K, Umeoka S, Kataoka M, Nagai S (2004) Radiologic manifestations of sarcoidosis in various organs. Radiographics 24(1):87–104PubMedCrossRef
46.
Zurück zum Zitat Warshauer DM, Lee JK (2004) Imaging manifestations of abdominal sarcoidosis. AJR Am J Roentgenol 182(1):15–28PubMedCrossRef Warshauer DM, Lee JK (2004) Imaging manifestations of abdominal sarcoidosis. AJR Am J Roentgenol 182(1):15–28PubMedCrossRef
47.
Zurück zum Zitat Dourakis SP, Cokkinos DD, Soultati AS, Alexopoulou A, Nezi V, Archimandritis AJ (2007) A case of liver sarcoidosis mimicking cirrhosis. Clin Imaging 31(1):47–49PubMedCrossRef Dourakis SP, Cokkinos DD, Soultati AS, Alexopoulou A, Nezi V, Archimandritis AJ (2007) A case of liver sarcoidosis mimicking cirrhosis. Clin Imaging 31(1):47–49PubMedCrossRef
48.
Zurück zum Zitat Deshpande V, Zen Y, Chan JK et al (2012) Consensus statement on the pathology of IgG4-related disease. Mod Pathol 25(9):1181–1192 Deshpande V, Zen Y, Chan JK et al (2012) Consensus statement on the pathology of IgG4-related disease. Mod Pathol 25(9):1181–1192
49.
Zurück zum Zitat Chen JH, Deshpande V (2017) IgG4-related disease and the liver. Gastroenterol Clin North Am 46(2):195–216PubMedCrossRef Chen JH, Deshpande V (2017) IgG4-related disease and the liver. Gastroenterol Clin North Am 46(2):195–216PubMedCrossRef
50.
Zurück zum Zitat Zen Y, Fujii T, Sato Y, Masuda S, Nakanuma Y (2007) Pathological classification of hepatic inflammatory pseudotumor with respect to IgG4-related disease. Mod Pathol 20(8):884–894PubMedCrossRef Zen Y, Fujii T, Sato Y, Masuda S, Nakanuma Y (2007) Pathological classification of hepatic inflammatory pseudotumor with respect to IgG4-related disease. Mod Pathol 20(8):884–894PubMedCrossRef
51.
Zurück zum Zitat Akatsu T, Wakabayashi G, Tanimoto A, Kameyama K, Kitajima M (2006) Inflammatory pseudotumor of the liver masquerading as hepatocellular carcinoma after a hepatitis B virus infection: report of a case. Surg Today 36(11):1028–1031PubMedCrossRef Akatsu T, Wakabayashi G, Tanimoto A, Kameyama K, Kitajima M (2006) Inflammatory pseudotumor of the liver masquerading as hepatocellular carcinoma after a hepatitis B virus infection: report of a case. Surg Today 36(11):1028–1031PubMedCrossRef
53.
Zurück zum Zitat Honmyo N, Kobayashi T, Tashiro H et al (2016) Inflammatory pseudotumor of the liver occurring during the course of hepatitis C virus-related hepatocellular carcinoma treatment: A case report. Int J Surg Case Rep 20:96–100PubMedPubMedCentralCrossRef Honmyo N, Kobayashi T, Tashiro H et al (2016) Inflammatory pseudotumor of the liver occurring during the course of hepatitis C virus-related hepatocellular carcinoma treatment: A case report. Int J Surg Case Rep 20:96–100PubMedPubMedCentralCrossRef
54.
Zurück zum Zitat Sakai M, Ikeda H, Suzuki N et al (2001) Inflammatory pseudotumor of the liver: case report and review of the literature. J Pediatr Surg 36(4):663–666PubMedCrossRef Sakai M, Ikeda H, Suzuki N et al (2001) Inflammatory pseudotumor of the liver: case report and review of the literature. J Pediatr Surg 36(4):663–666PubMedCrossRef
55.
Zurück zum Zitat Chen CB, Chou CT, Hsueh C, Lee KW, Chen YL (2013) Hepatic inflammatory pseudotumor mimicking hepatocellular carcinoma. J Chin Med Assoc 76(5):299–301PubMedCrossRef Chen CB, Chou CT, Hsueh C, Lee KW, Chen YL (2013) Hepatic inflammatory pseudotumor mimicking hepatocellular carcinoma. J Chin Med Assoc 76(5):299–301PubMedCrossRef
56.
Zurück zum Zitat Caramella T, Novellas S, Fournol M, Saint-Paul MC, Bruneton JN, Chevallier P (2007) Imaging of inflammatory pseudotumors of the liver. J Radiol 88(6):882–888 Caramella T, Novellas S, Fournol M, Saint-Paul MC, Bruneton JN, Chevallier P (2007) Imaging of inflammatory pseudotumors of the liver. J Radiol 88(6):882–888
57.
Zurück zum Zitat Roux M, Baranes L, Decaens T et al (2013) Recurring multicystic inflammatory pseudotumor of the liver: a case report. Clin Res Hepatol Gastroenterol 37(2):e51–e57PubMedCrossRef Roux M, Baranes L, Decaens T et al (2013) Recurring multicystic inflammatory pseudotumor of the liver: a case report. Clin Res Hepatol Gastroenterol 37(2):e51–e57PubMedCrossRef
58.
Zurück zum Zitat Ramamurthy NK, Rudralingam V, Martin DF, Galloway SW, Sukumar SA (2013) Out of sight but kept in mind: complications and imitations of dropped gallstones. AJR Am J Roentgenol 200(6):1244–1253PubMedCrossRef Ramamurthy NK, Rudralingam V, Martin DF, Galloway SW, Sukumar SA (2013) Out of sight but kept in mind: complications and imitations of dropped gallstones. AJR Am J Roentgenol 200(6):1244–1253PubMedCrossRef
59.
Zurück zum Zitat Sathesh-Kumar T, Saklani AP, Vinayagam R, Blackett RL (2004) Spilled gall stones during laparoscopic cholecystectomy: a review of the literature. Postgrad Med J 80(940):77–79PubMedPubMedCentralCrossRef Sathesh-Kumar T, Saklani AP, Vinayagam R, Blackett RL (2004) Spilled gall stones during laparoscopic cholecystectomy: a review of the literature. Postgrad Med J 80(940):77–79PubMedPubMedCentralCrossRef
60.
Zurück zum Zitat Rice DC, Memon MA, Jamison RL et al (1997) Long-term consequences of intraoperative spillage of bile and gallstones during laparoscopic cholecystectomy. J Gastrointest Surg 1(1):85–90 discussion 90-1PubMedCrossRef Rice DC, Memon MA, Jamison RL et al (1997) Long-term consequences of intraoperative spillage of bile and gallstones during laparoscopic cholecystectomy. J Gastrointest Surg 1(1):85–90 discussion 90-1PubMedCrossRef
61.
Zurück zum Zitat Levy AD, Murakata LA, Rohrmann CA Jr (2001) Gallbladder carcinoma: radiologic-pathologic correlation. Radiographics 21(2):295–314 questionnaire, 549-55PubMedCrossRef Levy AD, Murakata LA, Rohrmann CA Jr (2001) Gallbladder carcinoma: radiologic-pathologic correlation. Radiographics 21(2):295–314 questionnaire, 549-55PubMedCrossRef
62.
Zurück zum Zitat Ros PR, Goodman ZD (1997) Xanthogranulomatous cholecystitis versus gallbladder carcinoma. Radiology 203(1):10–12PubMedCrossRef Ros PR, Goodman ZD (1997) Xanthogranulomatous cholecystitis versus gallbladder carcinoma. Radiology 203(1):10–12PubMedCrossRef
63.
Zurück zum Zitat Zhao F, Lu PX, Yan SX et al (2013) CT and MR features of xanthogranulomatous cholecystitis: an analysis of consecutive 49 cases. Eur J Radiol 82(9):1391–1397PubMedCrossRef Zhao F, Lu PX, Yan SX et al (2013) CT and MR features of xanthogranulomatous cholecystitis: an analysis of consecutive 49 cases. Eur J Radiol 82(9):1391–1397PubMedCrossRef
64.
Zurück zum Zitat Saluja SS, Ray S, Pal S et al (2007) Hepatobiliary and pancreatic tuberculosis: a two decade experience. BMC Surg 7:10 Saluja SS, Ray S, Pal S et al (2007) Hepatobiliary and pancreatic tuberculosis: a two decade experience. BMC Surg 7:10
65.
Zurück zum Zitat Fan ST, Ng IO, Choi TK, Lai E (1989) Tuberculosis of the bile duct: a rare cause of biliary stricture. Am J Gastroenterol 84(4):413–414 Fan ST, Ng IO, Choi TK, Lai E (1989) Tuberculosis of the bile duct: a rare cause of biliary stricture. Am J Gastroenterol 84(4):413–414
66.
Zurück zum Zitat Vlachou PA, Khalili K, Jang HJ, Fischer S, Hirschfield GM, Kim TK (2011) IgG4-related sclerosing disease: autoimmune pancreatitis and extrapancreatic manifestations. Radiographics 31(5):1379–1402PubMedCrossRef Vlachou PA, Khalili K, Jang HJ, Fischer S, Hirschfield GM, Kim TK (2011) IgG4-related sclerosing disease: autoimmune pancreatitis and extrapancreatic manifestations. Radiographics 31(5):1379–1402PubMedCrossRef
67.
Zurück zum Zitat Hedgire SS, McDermott S, Borczuk D, Elmi A, Saini S, Harisinghani MG (2013) The spectrum of IgG4-related disease in the abdomen and pelvis. AJR Am J Roentgenol 201(1):14–22PubMedCrossRef Hedgire SS, McDermott S, Borczuk D, Elmi A, Saini S, Harisinghani MG (2013) The spectrum of IgG4-related disease in the abdomen and pelvis. AJR Am J Roentgenol 201(1):14–22PubMedCrossRef
68.
Zurück zum Zitat Martínez-de-Alegría A, Baleato-González S, García-Figueiras R et al (2015) IgG4-related disease from head to toe. Radiographics 35(7):2007–2025PubMedCrossRef Martínez-de-Alegría A, Baleato-González S, García-Figueiras R et al (2015) IgG4-related disease from head to toe. Radiographics 35(7):2007–2025PubMedCrossRef
69.
Zurück zum Zitat Ryan DP, Hong TS, Bardeesy N (2014) Pancreatic adenocarcinoma. N Engl J Med 371(22):2140–2141PubMed Ryan DP, Hong TS, Bardeesy N (2014) Pancreatic adenocarcinoma. N Engl J Med 371(22):2140–2141PubMed
70.
Zurück zum Zitat Hart PA, Zen Y, Chari ST (2015) Recent advances in autoimmune pancreatitis. Gastroenterology 149(1):39–51PubMedCrossRef Hart PA, Zen Y, Chari ST (2015) Recent advances in autoimmune pancreatitis. Gastroenterology 149(1):39–51PubMedCrossRef
71.
Zurück zum Zitat Zhang L, Chari S, Smyrk TC et al (2011) Autoimmune pancreatitis (AIP) type 1 and type 2: an international consensus study on histopathologic diagnostic criteria. Pancreas 40(8):1172–1179PubMedCrossRef Zhang L, Chari S, Smyrk TC et al (2011) Autoimmune pancreatitis (AIP) type 1 and type 2: an international consensus study on histopathologic diagnostic criteria. Pancreas 40(8):1172–1179PubMedCrossRef
72.
Zurück zum Zitat Lee LK, Sahani DV (2014) Autoimmune pancreatitis in the context of IgG4-related disease: review of imaging findings. World J Gastroenterol 20(41):15177–15189PubMedPubMedCentralCrossRef Lee LK, Sahani DV (2014) Autoimmune pancreatitis in the context of IgG4-related disease: review of imaging findings. World J Gastroenterol 20(41):15177–15189PubMedPubMedCentralCrossRef
73.
Zurück zum Zitat Wakabayashi T, Kawaura Y, Satomura Y et al (2003) Clinical and imaging features of autoimmune pancreatitis with focal pancreatic swelling or mass formation: comparison with so-called tumor-forming pancreatitis and pancreatic carcinoma. Am J Gastroenterol 98(12):2679–2687PubMedCrossRef Wakabayashi T, Kawaura Y, Satomura Y et al (2003) Clinical and imaging features of autoimmune pancreatitis with focal pancreatic swelling or mass formation: comparison with so-called tumor-forming pancreatitis and pancreatic carcinoma. Am J Gastroenterol 98(12):2679–2687PubMedCrossRef
74.
Zurück zum Zitat Fattahi R, Balci NC, Perman WH et al (2009) Pancreatic diffusion-weighted imaging (DWI): comparison between mass-forming focal pancreatitis (FP), pancreatic cancer (PC), and normal pancreas. J Magn Reson Imaging 29(2):350–356PubMedCrossRef Fattahi R, Balci NC, Perman WH et al (2009) Pancreatic diffusion-weighted imaging (DWI): comparison between mass-forming focal pancreatitis (FP), pancreatic cancer (PC), and normal pancreas. J Magn Reson Imaging 29(2):350–356PubMedCrossRef
75.
Zurück zum Zitat Patlas M, Deitel W, Taylor B, Gallinger S, Wilson SR (2007) Focal chronic pancreatitis mimicking pancreatic head carcinoma: are there suggestive features on ultrasound? Can Assoc Radiol J 58(1):15–21 Patlas M, Deitel W, Taylor B, Gallinger S, Wilson SR (2007) Focal chronic pancreatitis mimicking pancreatic head carcinoma: are there suggestive features on ultrasound? Can Assoc Radiol J 58(1):15–21
76.
Zurück zum Zitat Johnson PT, Outwater EK (1999) Pancreatic carcinoma versus chronic pancreatitis: dynamic MR imaging. Radiology 212(1):213–218PubMedCrossRef Johnson PT, Outwater EK (1999) Pancreatic carcinoma versus chronic pancreatitis: dynamic MR imaging. Radiology 212(1):213–218PubMedCrossRef
78.
Zurück zum Zitat Zacharia GS, Antony R, Kolassery S, Ramachandran TM (2014) Isolated pancreatic tuberculosis masquerading as pancreatic cancer. Gastroenterol Rep (Oxf) 2(2):154–157PubMedPubMedCentralCrossRef Zacharia GS, Antony R, Kolassery S, Ramachandran TM (2014) Isolated pancreatic tuberculosis masquerading as pancreatic cancer. Gastroenterol Rep (Oxf) 2(2):154–157PubMedPubMedCentralCrossRef
79.
Zurück zum Zitat Falkowski AL, Graber J, Haack HG, Tarr PE, Rasch H (2013) Isolated pancreatic tuberculosis: a case report and radiological comparison with cystic pancreatic lesions. J Radiol Case Rep 7(1):1–11 Falkowski AL, Graber J, Haack HG, Tarr PE, Rasch H (2013) Isolated pancreatic tuberculosis: a case report and radiological comparison with cystic pancreatic lesions. J Radiol Case Rep 7(1):1–11
80.
Zurück zum Zitat Hart RG, Kagan-Hallet K, Joerns SE (1987) Mechanisms of intracranial hemorrhage in infective endocarditis. Stroke 18(6):1048–1056PubMedCrossRef Hart RG, Kagan-Hallet K, Joerns SE (1987) Mechanisms of intracranial hemorrhage in infective endocarditis. Stroke 18(6):1048–1056PubMedCrossRef
82.
Zurück zum Zitat Sheil AG, Reeve TS, Little JM, Coupland GA, Loewenthal J (1969) Aorto-intestinal fstulas following operations on the abdominal aorta and iliac arteries. Br J Surg 56(11):840–843PubMedCrossRef Sheil AG, Reeve TS, Little JM, Coupland GA, Loewenthal J (1969) Aorto-intestinal fstulas following operations on the abdominal aorta and iliac arteries. Br J Surg 56(11):840–843PubMedCrossRef
Metadaten
Titel
Non-neoplastic hepatopancreatobiliary lesions simulating malignancy: can we differentiate?
verfasst von
Ali Devrim Karaosmanoglu
Aycan Uysal
Musturay Karcaaltincaba
Deniz Akata
Mustafa Nasuh Ozmen
Jessica Kraeft
Peter F. Hahn
Publikationsdatum
01.12.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Insights into Imaging / Ausgabe 1/2020
Elektronische ISSN: 1869-4101
DOI
https://doi.org/10.1186/s13244-019-0813-8

Weitere Artikel der Ausgabe 1/2020

Insights into Imaging 1/2020 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

13.04.2024 Klinik aktuell Kongressbericht

Die Teilnehmer eines Forums beim DGIM-Kongress waren sich einig: Fehler in der Medizin sind häufig in ungeeigneten Prozessen und mangelnder Kommunikation begründet. Gespräche mit Patienten und im Team können helfen.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.